NCT07197554
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07197554
Title A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SEED Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
The City of Hope National Medical Center RECRUITING Duarte California 91010 United States Details
Hoag Memorial Hospital RECRUITING Newport Beach California 92263 United States Details
Mass General Brigham Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center NOT_YET_RECRUITING New York New York 10065 United States Details
The University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field